Changes in the proteomic profile of blood serum in coronary atherosclerosis and abdominal obesity
- 30 June 2026
- journal article
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 22 (2)
Abstract
Background – to study the relationship of blood proteins with abdominal obesity in patients with coronary atherosclerosis by quantitative proteomic analysis. Methods. The study involved patients with coronary atherosclerosis ( n = 36), with an average age of 57 ± 7 years. The research material is blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit. The identification of protein fractions was carried out by monitoring multiple reactions on a Q-TRAP 6500 mass spectrometer combined with a liquid chromatograph. Results. Mass spectrometric identification revealed lower concentrations of proteins in blood serum samples from patients with coronary atherosclerosis and abdominal obesity: serum albumin, apolipoproteins A (I, IV), C (I, III, IV), L1, thrombospondin 1, PAI 1, coagulation factors (X, XII), complement factor H, fibronectin, CD5 antigenlike protein, phospholipid-transferring protein, gelsolin and osteonectin, compared with those without AO. The differences were considered significant at p < 0.05. In patients with coronary atherosclerosis, a correlation was found between AO and osteonectin (r = –0.603; p = 0.0001). In addition, the presence of AO is associated with the concentration of osteonectin (B = –0,087; Exp(B) = 0,916; ДИ 0,843– 0,996; p = 0,039) and gelsolin (B = –0,092; Exp(B) = 0,912; ДИ 0,839–0,991; p = 0,029). Conclusions. In this study, we found a decrease in blood concentrations of proteins associated with the inflammatory process, lipid metabolism, adaptive immune responses in coronary atherosclerosis and AO. In addition, in coronary atherosclerosis, the reverse association of AO with gelzolin and osteonectin, a well-known marker of arterial calcification, was revealed. These results can serve as a basis for further research, as well as for a better understanding of the effect of AO on coronary atherosclerosis.This publication has 23 references indexed in Scilit:
- Association of Cumulative Exposure to Metabolic Score for Visceral Fat With the Risk of Cardiovascular Disease and All‐Cause Mortality: A Prospective Cohort StudyJournal of Cachexia, Sarcopenia and Muscle, 2025
- The matricellular protein SPARC induces inflammatory interferon-response in macrophages during agingImmunity, 2022
- Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypesMultiple Sclerosis and Related Disorders, 2021
- The Role of Phospholipid Transfer Protein in the Development of AtherosclerosisCurrent Atherosclerosis Reports, 2021
- Duration and stability of metabolically healthy obesity over 30 yearsInternational Journal of Obesity, 2018
- Adipokines and inflammation: is it a question of weight?British Journal of Pharmacology, 2018
- SPARC/osteonectin in mineralized tissueMatrix Biology, 2016
- Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarizationAmerican Journal of Physiology-Cell Physiology, 2015
- Thrombosis formation on atherosclerotic lesions and plaque ruptureJournal of Internal Medicine, 2014
- Long chain acyl CoA synthetase 1 and gelsolin are oppositely regulated in adipogenesis and lipogenesisBiochemical and Biophysical Research Communications, 2012